They observed high levels of CTR1 expression in melanoma cells (B16F10, A375M, MDA-MB-435 (26)) and suggested that CTR1 could be a new target for imaging and therapy of malignant melanoma. This evidence concerns the gene SLC31A1 and melanoma.